The High Court has decisively rejected Huawei's second application for a case management stay in its patent dispute with ...

Here are six new drug shortages and discontinuations, according to drug supply databases from the FDA.

The college announced Tuesday it will continue to operate the two hotels it purchased last year as regular hotels, amid ...

Torrent Pharma makes a bold ₹18,000 crore move to acquire JB Chemicals, signalling a strategic comeback and consolidation ...

Stanford University researchers have discovered why some people with attention deficit hyperactivity disorder may do well on ...

Detailed price information for Teva Pharmaceutical Industries ADR (TEVA-N) from The Globe and Mail including charting and ...

A U.S. appeals court on Thursday upheld three Tris Pharma Inc patents covering a form of its ADHD drug Quillivant, rejecting a challenge from Teva Pharmaceuticals-owned generic drugmaker Actavis ...

Actavis. The Supreme Court held settlements by which brand-name drug companies pay generics to settle patent litigation and delay entering the market could have significant anticompetitive effects ...

Actavis UK's current owner, Teva, said it would defend the allegations. Between 2008 and 2015, the CMA claims that the NHS's spending on the drug rose from £522,000 to £70m.

September 22, 2016 at 12:00 AM 1 minute read By | Updated on September 22, 2016 Justice Barry Ostrager Read Full-Text Decision ...

Actavis Gets Wide-Moat Upgrade With Acquisition of Allergan Through acquisitions, Actavis has transformed into a globally diversified drug manufacturer with considerable low-cost advantages ...